Clinical Applications
Megan Levings, PhD
School of Biomedical Engineering
University of British Columbia, Canada
Sonja Schrepfer, MD, PhD
Surgery and Genomic Immunology
Sana Biotechnology Inc. and UCSF, United States
Lili Yang, PhD
Microbiology, Immunology and Molecular Genetics
University of California, Los Angeles (UCLA), United States
This session will highlight ways to either enhance or suppress the immune system to target a range of conditions like solid tumors, metabolic dysfunction, fibrosis and autoimmune diseases. We will explore innovations in CAR T cells, pluripotent stem cell-derived-macrophages and natural killer (NK) cells, all currently in clinical trials. Additionally, the session will discuss hypoimmune cells and the immune privilege of transplanted cells.
Concurrent Speaker: Megan Levings, PhD – University of British Columbia
Presenting Author: Lili Yang, PhD – University of California, Los Angeles (UCLA)
Concurrent Speaker: Sonja Schrepfer, MD, PhD – Sana Biotechnology Inc. and UCSF